200 81000 advanced:3.55891312765391 year:1.51122028428865 reason:3.55891312765391 cancer:4.63203032133495 case:0.325148690291958 cohort:2.32203570971108 investigators:1.68711095075232 control:0.919855798038651 design:2.29943659920322 draw:1.80971327284465 grow:0.802072762382268 study:1.94947521521981 eric:4.53974238066564 figure:1.80971327284465 men:2.38025813131226 follow:2.04646830498498 men:2.38025813131226 gonna:3.55891312765391 entire:3.15344801954575 health:2.6957904563707 free:1.44869992730732 questionnaire:2.27105883934727 year:0.675510039073838 started:1.66806275578162 50000:3.84659520010569 levels:1.07400647786591 lorelei:4.53974238066564 1986:4.08506565095307 mucci:4.25206030821386 source:8.50412061642772 nested:2.93030446823154 nail:1.0844777777332 professionals:6.88226018399506 prostate:7.69319040021138 invited:2.74798291143758 interesting:0.834333624600489 remember:0.417998844255421 researchers:3.89895043043962 rimm:4.53974238066564 risk:0.614474148487469 selenium:3.84659520010569 toenails:2.54731221597543 started:1.49601108222398 study:2.66418375632041 biomarkers:0.859231176222216 talk:0.84683782344952 thought:3.84956520525888 thought:8.0578335137993 undertook:4.53974238066564 men:0.970126149671934
81000 165550 1987:3.24045939653538 author:0.489454245962768 biological:3.24045939653538 population:0.650297380583916 back:7.69319040021138 clipping:4.02891675689965 1996:1.68711095075232 nested:1.8397115960773 control:9.8904149775476 factors:0.90215622093925 health:1.02323415249249 stored:3.84659520010569 study:4.9452074887738 happened:0.60791674794131 37000:1.34789522818535 giovannucci:3.80672045060016 hypothesis:9.8904149775476 levels:2.14801295573182 toenails:1.66806275578162 toenails:2.74798291143758 hypothesis:0.793215308548206 50000:2.72337710063538 source:5.86060893646308 study:0.514390689930487 previous:0.867670044868081 man:3.44113009199753 study:2.38025813131226 larry:1.17244655067916 study:1.38985942728439 reflect:1.49521994294221 back:7.69319040021138 follow:2.54731221597543 specimens:3.69244452027843 1996:2.99929733971849 study:2.66418375632041 taking:0.859231176222216 toenail:16.1156670275986 clark:1.54401010711165 funds:4.53974238066564 study:0.956223442209526 year:0.485063074835967
165550 247620 1994:7.11782625530782 study:1.28164584264415 advanced:6.1760404284466 prostate:1.30059476116783 compare:3.84659520010569 follow:0.634408363388287 set:2.75956739411595 number:0.87618073453599 ed:4.9452074887738 1996:0.802072762382268 toenail:2.41947884446554 professionals:0.778542264972074 ended:2.04646830498498 researchers:1.76715365842585 risk:2.6957904563707 remember:1.83169217956343 find:4.9452074887738 means:0.810040932031445 study:0.526366880977203 found:4.53974238066564 identified:4.08506565095307 prostate:5.86060893646308 set:0.153557735843091 cancer:1.57791165878733 undertook:1.78820706762369 trial:0.514390689930487 set:6.88226018399506 basically:11.5397856003171 results:1.17244655067916 order:0.417998844255421 health:1.94947521521981 study:0.634408363388287 prostate:2.45789659394988 cases:1.33708273951549 risk:2.89739985461464 cancer:1.12699344128658 larry:3.69244452027843 randomized:2.54731221597543 men:3.69244452027843 follow:1.77612250421361 men:0.0700101655726489 37000:4.02891675689965 epidemiological:1.54401010711165 advanced:4.53974238066564
247620 320340 develop:7.11782625530782 study:3.24045939653538 controls:0.550758334101362 prostate:3.0880202142233 follow:0.650297380583916 randomized:1.14971829960161 control:2.32203570971108 prostate:0.634408363388287 question:2.54731221597543 cancer:1.8397115960773 questions:3.44113009199753 read:2.11199414471758 men:1.75236146907198 relative:0.748005541111992 years:2.04646830498498 risk:1.76715365842585 men:3.15344801954575 selenium:3.22201943359773 risk:0.984394319176222 toenails:1.47947158597407 compared:3.44113009199753 toenails:0.793215308548206 study:2.69391569016731 33000:5.44675420127076 authors:2.93030446823154 follow:0.153557735843091 calculate:0.984394319176222 chance:1.7263316639056 advanced:7.69319040021138 detail:1.56108257075097 line:1.17244655067916 odds:0.654748047625409 trial:1.52748080516043 measure:4.68503560665884 estimate:0.634408363388287 relative:1.84342244546241 measured:7.69319040021138 thinking:0.888061252106805 paper:0.42341891172476 talk:1.83169217956343 men:12.0867502706989 results:1.54401010711165 toenails:0.970126149671934
320340 394540 address:2.14184710786727 advanced:7.11782625530782 bit:0.550758334101362 cancer:4.63203032133495 case:0.975446070875874 complex:2.4603008389858 control:2.75956739411595 definition:1.68711095075232 design:1.14971829960161 diagnosed:6.67225102312648 discuss:1.9747930232041 1993:5.73153189418792 identified:1.83169217956343 question:0.396607654274103 control:0.153557735843091 participant:7.69913041051776 question:0.582108863985438 population:0.514390689930487 risk:2.95894317194814 principles:2.80514132527753 prostate:11.5397856003171 question:3.12216514150195 1990:1.28164584264415 researchers:1.94947521521981 risk:2.45789659394988 sampling:2.00562410927323 set:1.12699344128658 source:2.54731221597543
394540 468940 years:1.70652903660942 concerned:3.9495860464082 limitations:2.64262239577975 case:0.325148690291958 categorize:2.59383223161032 complicated:2.59383223161032 core:1.92478260262944 finally:2.08300660784433 continuous:1.49521994294221 exposure:4.25206030821386 divided:0.725699783597694 concepts:1.43366204994278 equal:0.462204936759917 exposure:7.76729548488036 exposure:1.21951406153715 study:0.778542264972074 groups:0.249282939517245 happened:0.60791674794131 recently:1.94947521521981 influence:1.52748080516043 levels:1.07400647786591 potential:1.66806275578162 measure:1.58643061709641 oftentimes:9.8904149775476 findings:1.47947158597407 question:0.520360856916991 quintiles:4.53974238066564 reflect:3.07340531187221 reflect:2.99043988588442 epidemiology:1.28164584264415 selenium:11.5397856003171 simply:2.59383223161032 study:0.888061252106805 things:0.209009040379305 window:2.38025813131226 20:0.485063074835967 yesno:4.25206030821386
468940 542480 cancer:3.55891312765391 cancer:1.70652903660942 secondary:1.14971829960161 found:1.11656609228471 undertaken:1.00362568110411 bias:1.9747930232041 studies:3.55891312765391 selenium:1.40424816473649 risk:6.1760404284466 clark:3.84659520010569 compare:1.26881672677657 contrast:3.3357695763397 randomized:2.41947884446554 estimate:0.748005541111992 final:1.21951406153715 1996:3.5343073168517 gonna:3.55891312765391 great:2.34251780332942 influence:3.89895043043962 national:3.3357695763397 blood:2.99929733971849 larry:4.9452074887738 association:1.07400647786591 selenium:1.47947158597407 analysis:2.72337710063538 years:2.4603008389858 men:2.5028604534046 potential:1.47947158597407 lower:11.5397856003171 published:2.38025813131226 question:1.04072171383398 randomized:3.51733965203748 relative:2.34251780332942 relates:1.28164584264415 risk:2.45789659394988 found:4.02891675689965 undertook:2.89739985461464 randomized:11.5397856003171 trail:1.29454924748006 study:1.77612250421361 subsequent:3.07340531187221 biomarkers:4.02891675689965 trial:4.9452074887738 study:1.54401010711165 undertaken:13.6192271419969 cancer:4.53974238066564 prostate:0.485063074835967
542480 618410 guess:2.02743675668952 agent:2.93030446823154 found:1.11656609228471 placebo:2.1689555554664 randomized:0.281768394661733 cancer:7.72005053555825 chemo:4.9452074887738 larry:3.84659520010569 conducted:2.54731221597543 years:3.3357695763397 disadvantages:0.919855798038651 data:0.231182897873627 factorial:1.14971829960161 time:2.64262239577975 question:2.99929733971849 evidence:0.96552583487184 epidemiological:4.83895768893108 104:1.87715455364018 called:3.44113009199753 published:1.02323415249249 study:3.5343073168517 prostate:2.64262239577975 states:2.64262239577975 results:4.9452074887738 35000:1.36168855031769 vitamin:2.5028604534046 potential:1.47947158597407 preventive:7.78149669483096 primary:2.38025813131226 prostate:15.3863808004228 found:3.07340531187221 study:2.38025813131226 cancer:0.520360856916991 diagnosis:3.51733965203748 design:1.87715455364018 recruited:3.07340531187221 cancer:2.34251780332942 studies:0.634408363388287 selenium:1.22894829697494 selenium:23.0795712006341 united:1.41884696415764 average:1.18408166947574 effect:3.69244452027843 thinking:1.83169217956343 cancer:0.0700101655726489 men:1.70652903660942 selenium:5.99859467943698 study:0.485063074835967
618410 654100 answers:0.538488241509547 bias:1.9747930232041 comments:2.86576594709396 compared:0.634408363388287 comparison:1.9747930232041 concerned:2.08300660784433 confounding:1.36168855031769 controlled:0.919855798038651 critique:6.88226018399506 epidemiological:4.83895768893108 explanations:2.38025813131226 exposure:1.29454924748006 final:1.21951406153715 forward:2.30615015915854 interpretation:1.52748080516043 letting:3.24045939653538 logging:2.34251780332942 outcomes:0.654748047625409 part:1.0844777777332 plausible:3.44113009199753 post:2.86576594709396 providing:2.05483573087764 question:1.56108257075097 randomized:1.17244655067916 study:1.18408166947574 thoughts:1.92478260262944 trial:1.54401010711165
